methylprednisolone has been researched along with Hyperpigmentation in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hong, JY; Kim, BJ; Kim, MN; Lee, HW; Park, KY | 1 |
| Patel, AN; Perkins, W; Ravenscroft, A; Varma, S | 1 |
| Englert, H; Katelaris, C; McGill, N; Moore, J; Schrieber, L | 1 |
3 other study(ies) available for methylprednisolone and Hyperpigmentation
| Article | Year |
|---|---|
Brimonidine tartrate gel plus topical steroid for the prevention of laser therapy-related postinflammatory hyperpigmentation.
Topics: Administration, Cutaneous; Adrenergic alpha-2 Receptor Agonists; Anti-Inflammatory Agents; Brimonidine Tartrate; Dermatitis; Gels; Humans; Hyperpigmentation; Lasers, Solid-State; Lentigo; Male; Methylprednisolone; Middle Aged | 2018 |
Extraordinary reticulate hyperpigmentation occurring after Bier block.
Topics: Anesthetics, Local; Anti-Inflammatory Agents; Female; Foot Injuries; Humans; Hyperpigmentation; Methylprednisolone; Nerve Block; Prilocaine; Young Adult | 2013 |
'Grape-sultana' sign represents a favourable response to aggressive treatment of early diffuse systemic scleroderma.
Topics: Adult; Bone Marrow Transplantation; Cyclophosphamide; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Hyperpigmentation; Immunosuppressive Agents; Methylprednisolone; Scleroderma, Diffuse | 2005 |